Saturday 17 October 2026
Export POM’s income statement to Excel — free account
Pomdoctor Limited - Sponsored ADR
POM Healthcare Pharmaceutical Retailers
Pomdoctor Limited - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $57.2 million, up 21.9% from fiscal 2024.
0.61
0.10
−14.08%
Follow POM
| Dec '25 | Dec '24 | |
|---|---|---|
Altman Z-Score |
(33.29) | — |
Altman Z″-Score (non-manufacturers) |
(90.22) | (184.50) |
Beneish M-Score |
0.80 | — |
P/Operating CF |
0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 |
EV/FCF |
0.00 | 0.00 |
Quick Ratio |
0.44 | 0.15 |
Current Ratio |
0.48 | 0.21 |
Net Debt/EBITDA |
(3.73) | (16.77) |
Debt/Assets |
420.33% | 947.57% |
Debt/Equity |
(0.94) | (0.19) |
Asset Turnover |
5.27 | 0.00 |
Operating CF/Net income |
0.70 | 0.11 |
Capex/Depreciation |
(6.73) | (0.25) |
Interest Coverage |
(9.21) | (1.99) |
| 16.05% | 0.00% | |
| (279.99%) | 0.00% | |
ROIC |
0.00% | 0.00% |
Return on Tangible Assets |
189.88% | 101.54% |
Average Days of Receivables |
78.88 | 21.04 |
Research and Development Expense of Revenue |
3.22% | 0.88% |
Selling, General and Administrative Expense of Revenue |
38.99% | 19.92% |
Intangible Assets out of Total Assets |
0.00 | 0.00 |
Share Based Compensation of Revenue |
4.11% | 0.00% |
Graham Net Nets |
0.00 | 0.00 |
Graham Number |
0.00 | 0.00 |
Free Cash Flow per Share |
(6.63) | (1.05) |
Cash per Share |
0.43 | 0.50 |
Shareholders Equity per Share |
(21.35) | (147.58) |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
(21.35) | (147.58) |
Free Cash Flow |
(21.38) | (2.21) |
Working Capital |
(16.19) | (19.41) |
Capital Expenditures |
(0.14) | 0.00 |
Net Current Asset Value |
(69.19) | (311.28) |
EV/EBIT |
0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 |
| Other line items | ||
Depreciation/Fixed assets |
0.12 | 0.29 |
Cash ROIC |
762.08% | 0.89% |
Accounts Receivable Turnover |
7.59 | 0.00 |
Accounts Payable Turnover |
10.06 | 0.00 |
Inventory Turnover |
40.75 | 0.00 |
Average Days of Payables |
47.06 | 31.37 |
Days of Inventory on Hand |
8.69 | 11.35 |
Revenue per Share |
17.74 | 22.34 |
Operating CF per Share |
(6.59) | (1.05) |
Capex per Share |
(0.04) | 0.00 |
Average Receivables |
7.53 | — |
Average Payables |
4.94 | — |
Average Inventory |
1.22 | — |
Average Assets |
10.86 | — |
Average Common Equity |
(189.45) | — |
Columns are period end dates · fundamentals updated 1 Oct 2026